New study tracks rare disease MLIV to map its natural course

This study looks back at medical records of 50 people with Mucolipidosis Type IV (MLIV) to learn how the disease typically progresses. Researchers want to know when children reach or lose developmental milestones, how their movement and vision change, and what lab results look like. The goal is to better understand MLIV, which may help design future treatments.